Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433113 | PMC |
| http://dx.doi.org/10.3389/fspor.2022.1006035 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nurse education in Asia: A microcosm of the changing world.
Nurse Educ Today
December 2024
School of Nursing, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong. Electronic address:
Advancing space medicine: a global perspective on in-orbit research and future directions.
Mil Med Res
January 2025
State Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Training Community Clinicians in Implementing CBT-ERP for Youth with OCD: A Pilot Study in Australian Community Mental Health Services.
Child Psychiatry Hum Dev
January 2025
School of Applied Psychology, Griffith University, Gold Coast, QLD, Australia.
This pilot study evaluated the outcomes associated with a training workshop in cognitive-behavioural therapy with exposure and response prevention (ERP) for youth with obsessive-compulsive disorder (OCD) aimed at improving clinicians' capabilities and motivations. Questionnaires and role-plays were completed by 17 Australian clinicians working across community youth (i.e.
View Article and Find Full Text PDFMind over matter: The role of mental performance coaching in surgical training.
Am J Surg
December 2024
Medical University of South Carolina, Department of Surgery, Charleston, SC, 29403, USA. Electronic address:
Historical and political context for Philip Morris International's continuing medical education courses on harm reduction.
Tob Control
January 2025
Retired, University of California San Francisco, San Francisco, California, USA.
In 2024, Philip Morris International's (PMI) website stated they support 'independent' continuing medical education courses on harm reduction for medical and other healthcare professionals. These courses mirrored industry marketing and political strategies by presenting smokeless tobacco products and e-cigarettes as alternatives to smoking, sometimes without mentioning tobacco cessation. The enactment of the US Family Smoking and Tobacco Control Act gave the US Food and Drug Agency jurisdiction over tobacco products and included the industry's 'continuum of risk' frame, and emboldened tobacco companies to make harm reduction claims about these products, which they had previously avoided for fear of triggering restrictive regulation of cigarettes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!